Sweden· SE-20161011000015
Trelema 50 mg + 100 mg + 150 mg + 200 mg Filmdragerad tablett
A medicinal product containing lacosamide, registered in Sweden by G.L. Pharma GmbH.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Lacosamide
- Manufacturer
- G.L. Pharma GmbH
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20161011000015
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lacosamide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaARKVIMMANeuraxpharm Bohemia s.r.o., Praha
- SpainBALMID 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGIntas Third Party Sales 2005 S.L.
- United StateslacosamideMSN LABORATORIES PRIVATE LIMITED
- ItalyLACOSAMIDE ACCORDACCORD HEALTHCARE SLU
- NetherlandsCosim 50 mg filmomhulde tablettenGedeon Richter Plc.
- BelgiumLacosamide AB 50 mgAurobindo
- FranceLACOSAMIDE ACCORD 50 mg, comprimé pelliculéACCORD HEALTHCARE (ESPAGNE)
- IcelandJosamecInnovis Pharma S.A.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Lacopat, Lacopat Packung Zur Behandlungseinleitung
- Belgium · Lacosamid Hikma, Lacosamide Eg
- Bulgaria · Канилад, Лакозамид Гриндекс
- Cyprus · Kanilad, Lacosadel
- Czechia · Arkvimma, Kanilad
- Germany · Kanilad, Lackepila
- Denmark · 200 mg, Lacosamid Opko Health Spain
- Estonia · Kanilad, Lacosamide Alembic
- Spain · Balmid, Kanilad
- Finland · Lacosamide Fresenius Kabi, Lacosamide Grindeks
- France · Lacosamide Arrow, Lacosamide Biogaran
- United Kingdom (Northern Ireland) · Lacosamide, Lacosamide Amarox
- Greece · Anlamyl, Josamec
- Croatia · Kanilad, Lacosamide Grindeks
- Hungary · Anlamyl, Arkvimma
- Ireland · Lacosamide Ascend, Lacosamide Fresenius Kabi
- Iceland · Josamec, Lacosamide Accord
- Italy · Lacosamide Aurobindo, Lacosamide Doc
- Liechtenstein · Lacosamid Fresenius Kabi, Lacosamide Accord
- Lithuania · Lacosamide Fresenius Kabi, Lacosamide Grindeks
- Luxembourg · Lacosamide Eg
- Latvia · Kanilad, Lacosamide Fresenius Kabi
- Malta · Anlamyl, Kanilad
- Netherlands · Cosim, Lacosamide Amarox
- Norway · Lacosamide Accord, Lacosamide Fresenius Kabi
- Poland · Arkvimma, Epilantin
- Portugal · Lacosamida Alter, Lacosamida Aristo
- Romania · Lacosamidă Teva
- Slovenia · Lacosabil, Lacosamide Grindeks
- Slovakia · Arkvimma, Kanilad
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e1302456-d6d9-48a6-81d8-d98496c3e0ec GET /v1/drugs/e1302456-d6d9-48a6-81d8-d98496c3e0ec?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"PAR",
"sPAR",
"SmPC"
],
"se_npl_id": "20161011000015",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20161011000015",
"product_doc_link": "https://docetp.mpa.se/LMF/Trelema%20film-coated%20tablet%2C%20starter%20ENG%20SmPC_09001bee807a8146.pdf"
}See everything about lacosamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.